[1]
Thaçi, D., Lebwohl, M., Warren, R.B., Kircik, L., Banerjee, S., Napoli, A., Kisa, R.M., Linaberry, M., Hoyt, K. and Blauvelt, A. 2023. Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s243. DOI:https://doi.org/10.25251/skin.7.supp.243.